OSCR

Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Overview

Authors: Kelsi M. Chesney1, Jeffrey R. Whiteaker2, Brian Hood3, Ming Zhou4, Huizen Zhang1, Samuel Rivero-Hinojosa1, Amanda G. Paulovich2, Thomas P. Conrads4, Brian R. Rood1
  1. Brain Tumor Institute, Center for Cancer and Immunology Research, Children’s National Research Institute, Washington, DC 20010, USA; (K.M.C.)
  2. Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA
  3. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA
  4. Women’s Health Integrated Research Center, Women’s Service Line, Inova Health System, Annandale, VA 22003, USA
Institutions: Children's National (United States); University of Washington (United States); Fred Hutch Cancer Center (United States); Henry M. Jackson Foundation (United States); Inova Health System (United States)
Journal: Cells, volume 15, issue 5, article 474
Dates: received 14 January 2026; accepted 25 February 2026; published online 5 March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/cells15050474 · PMID 41827907 · PMCID PMC12984984 · OpenAlex W7133893679
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), other (modality), human (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics
Keywords: cerebrospinal fluid, pediatric brain tumors, proteomics, mass spectrometry, tumor-specific peptides, liquid biopsy, longitudinal disease monitoring, neuro-oncology
MeSH: Biomarkers, Tumor*, Brain Neoplasms*, Peptides*, Child, Child, Preschool, Female, Humans, Longitudinal Studies, Male, Medulloblastoma, Proteomics (* major topic)
Topic: Advanced Proteomics Techniques and Applications (Spectroscopy, Chemistry), according to OpenAlex
Funding: U.S. National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) (R50 CA211499, U01 CA271407); Lilabean Foundation (44844); Jeff Gordon Children’s Foundation (44568); Aven Foundation
Citations: cited by 1 paper (Europe PMC); 57 references in the paper

Abstract

Pediatric brain tumor survivors remain at high risk of recurrence, yet current surveillance strategies relying on neuroimaging and cerebrospinal fluid (CSF) cytology have limited sensitivity for early or minimal disease. Tumor-specific peptides (TSPs) derived from individual tumors represent a promising class of highly specific biomarkers for longitudinal disease monitoring through CSF-based proteomic analysis. In this study, tumor tissue and serial CSF samples from six pediatric brain tumor patients (five medulloblastomas and one atypical teratoid/rhabdoid tumor (ATRT)) were analyzed using an integrated proteogenomic workflow combining discovery and targeted mass spectrometry. TSPs were identified from resected tumor tissue and matched against shotgun CSF proteomic datasets to nominate candidate biomarkers. High-confidence peptides were synthesized as isotopically labeled standards and quantified longitudinally using targeted multiple reaction monitoring. Two TSP biomarkers derived from individualized pediatric brain tumors (one medulloblastoma and one ATRT) demonstrated robust detection in serial CSF samples and exhibited temporal concordance with radiographic disease course, declining with treatment response and increasing during disease progression. These findings establish the feasibility of detecting and longitudinally quantifying TSPs in CSF and support further investigation of individualized proteomic biomarkers for treatment response monitoring and disease surveillance in pediatric brain tumors.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The data presented in this study are not publicly available due to ethical and privacy restrictions related to patient confidentiality. De-identified data may be made available from the corresponding author upon reasonable request and with appropriate institutional approvals.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 8 keywords, 11 MeSH terms, 4 funders, 57 references.

Cite

This paper

Chesney, K. M., Whiteaker, J. R., Hood, B., Zhou, M., Zhang, H., Rivero-Hinojosa, S., Paulovich, A. G., Conrads, T. P., & Rood, B. R. (2026). Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance. Cells, 15(5), 474. https://doi.org/10.3390/cells15050474

BibTeX

@article{chesney2026longitudinal,
author = {Chesney, Kelsi M. and Whiteaker, Jeffrey R. and Hood, Brian and Zhou, Ming and Zhang, Huizen and Rivero-Hinojosa, Samuel and Paulovich, Amanda G. and Conrads, Thomas P. and Rood, Brian R.},
title = {{Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance}},
journal = {Cells},
year = {2026},
month = mar,
volume = {15},
number = {5},
pages = {474},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2073-4409},
doi = {10.3390/cells15050474},
url = {https://doi.org/10.3390/cells15050474},
pmid = {41827907},
pmcid = {PMC12984984}
}

RIS

TY - JOUR
AU - Chesney, Kelsi M.
AU - Whiteaker, Jeffrey R.
AU - Hood, Brian
AU - Zhou, Ming
AU - Zhang, Huizen
AU - Rivero-Hinojosa, Samuel
AU - Paulovich, Amanda G.
AU - Conrads, Thomas P.
AU - Rood, Brian R.
TI - Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance
T2 - Cells
J2 - Cells
PY - 2026
DA - 2026/03/05
VL - 15
IS - 5
SP - 474
SN - 2073-4409
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/cells15050474
UR - https://doi.org/10.3390/cells15050474
LA - en
ER -

CSL-JSON

{
"id": "10.3390/cells15050474",
"type": "article-journal",
"title": "Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance",
"container-title": "Cells",
"author": [
{
"family": "Chesney",
"given": "Kelsi M."
},
{
"family": "Whiteaker",
"given": "Jeffrey R."
},
{
"family": "Hood",
"given": "Brian"
},
{
"family": "Zhou",
"given": "Ming"
},
{
"family": "Zhang",
"given": "Huizen"
},
{
"family": "Rivero-Hinojosa",
"given": "Samuel"
},
{
"family": "Paulovich",
"given": "Amanda G."
},
{
"family": "Conrads",
"given": "Thomas P."
},
{
"family": "Rood",
"given": "Brian R."
}
],
"container-title-short": "Cells",
"volume": "15",
"issue": "5",
"page": "474",
"DOI": "10.3390/cells15050474",
"PMID": "41827907",
"PMCID": "PMC12984984",
"ISSN": "2073-4409",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/cells15050474",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
5
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s12276-026-01732-0
Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.
Journal: Experimental & molecular medicine
In common: genetics / omics, other condition, 4 references
[2] doi:10.1038/s43856-026-01454-4
An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.
Journal: Communications medicine
In common: clinical / translational, other condition, 3 references
[3] doi:10.7150/ijbs.116040
Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models.
Journal: International journal of biological sciences
In common: genetics / omics, other condition, 2 references
[4] doi:10.1007/s12017-026-08935-8
Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.
Journal: Neuromolecular medicine
In common: genetics / omics, other condition, 2 references
[5] doi:10.1111/bpa.70092
Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.
Journal: Brain pathology (Zurich, Switzerland)
In common: genetics / omics, other condition, 2 references
[6] doi:10.1093/narcan/zcag021 [code]
Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain.
Journal: NAR cancer
In common: genetics / omics, other condition, 1 reference
[7] doi:10.1038/s41598-026-47499-2 [code]
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.
Journal: Scientific reports
In common: genetics / omics, other condition, 1 reference
[8] doi:10.1186/s40478-026-02302-1
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.
Journal: Acta neuropathologica communications
In common: genetics / omics, other condition, 1 reference
[9] doi:10.1523/eneuro.0484-25.2026
Epigenetic and Transcriptomic Impacts of Ethanol Vary by Brain Region and Extent of Exposure.
Journal: eNeuro
In common: clinical / translational, genetics / omics, 1 reference
[10] doi:10.1038/s41467-026-72258-2
Mapping glioblastoma's isoform diversity using long-read single-cell analysis.
Journal: Nature communications
In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.